Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

141 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3 and terminal duct lobular unit involution of the breast: a cross-sectional study of women with benign breast disease.
Horne HN, Sherman ME, Pfeiffer RM, Figueroa JD, Khodr ZG, Falk RT, Pollak M, Patel DA, Palakal MM, Linville L, Papathomas D, Geller B, Vacek PM, Weaver DL, Chicoine R, Shepherd J, Mahmoudzadeh AP, Wang J, Fan B, Malkov S, Herschorn S, Hewitt SM, Brinton LA, Gierach GL. Horne HN, et al. Among authors: falk rt. Breast Cancer Res. 2016 Feb 18;18(1):24. doi: 10.1186/s13058-016-0678-4. Breast Cancer Res. 2016. PMID: 26893016 Free PMC article.
A case-control study of endogenous hormones and cervical cancer.
Shields TS, Falk RT, Herrero R, Schiffman M, Weiss NS, Bratti C, Rodriguez AC, Sherman ME, Burk RD, Hildesheim A. Shields TS, et al. Among authors: falk rt. Br J Cancer. 2004 Jan 12;90(1):146-52. doi: 10.1038/sj.bjc.6601514. Br J Cancer. 2004. PMID: 14710222 Free PMC article.
Variation in breast cancer hormone receptor and HER2 levels by etiologic factors: a population-based analysis.
Sherman ME, Rimm DL, Yang XR, Chatterjee N, Brinton LA, Lissowska J, Peplonska B, Szeszenia-Dabrowska N, Zatonski W, Cartun R, Mandich D, Rymkiewicz G, Ligaj M, Lukaszek S, Kordek R, Kalaylioglu Z, Harigopal M, Charrette L, Falk RT, Richesson D, Anderson WF, Hewitt SM, García-Closas M. Sherman ME, et al. Among authors: falk rt. Int J Cancer. 2007 Sep 1;121(5):1079-85. doi: 10.1002/ijc.22812. Int J Cancer. 2007. PMID: 17487843
Prolactin serum levels and breast cancer: relationships with risk factors and tumour characteristics among pre- and postmenopausal women in a population-based case-control study from Poland.
Faupel-Badger JM, Sherman ME, Garcia-Closas M, Gaudet MM, Falk RT, Andaya A, Pfeiffer RM, Yang XR, Lissowska J, Brinton LA, Peplonska B, Vonderhaar BK, Figueroa JD. Faupel-Badger JM, et al. Among authors: falk rt. Br J Cancer. 2010 Sep 28;103(7):1097-102. doi: 10.1038/sj.bjc.6605844. Epub 2010 Aug 24. Br J Cancer. 2010. PMID: 20736944 Free PMC article.
Genetic variation in PRL and PRLR, and relationships with serum prolactin levels and breast cancer risk: results from a population-based case-control study in Poland.
Nyante SJ, Faupel-Badger JM, Sherman ME, Pfeiffer RM, Gaudet MM, Falk RT, Andaya AA, Lissowska J, Brinton LA, Peplonska B, Vonderhaar BK, Chanock S, Garcia-Closas M, Figueroa JD. Nyante SJ, et al. Among authors: falk rt. Breast Cancer Res. 2011 Apr 6;13(2):R42. doi: 10.1186/bcr2864. Breast Cancer Res. 2011. PMID: 21470416 Free PMC article.
141 results